Abstract
Purpose of Review
Stress echocardiography (SE) is a well-established technique for the diagnosis and risk stratification of patients with known or suspected coronary artery disease (CAD). This review article summarizes the status of SE in CAD, including testing protocols, clinical efficacy and current use of newer technologies: myocardial perfusion, strain imaging, three-dimensional echocardiography and adjunctive carotid ultrasonography.
Recent Findings
Recent major findings in SE include the clinical value of myocardial perfusion imaging in multicentre studies, as well as when added to left ventricular (LV) wall motion assessment in clinical service. Additionally, SE has been shown to be more cost-effective than exercise ECG in patients with low-intermediate pre-test probability of CAD. Adjunctive atherosclerosis imaging by carotid ultrasonography (CU) to ischaemia testing by SE provides synergistic prognostic value, equivalent to hybrid imaging by PET-CT.
Summary
Despite the development of newer and more expensive imaging modalities, SE remains the cornerstone for the assessment of CAD and has excellent clinical efficacy, is safe and is cost-effective.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Senior R, Monaghan M, Becher H, et al. Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography. Heart. 2005;91:427–36.
Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J. 2007;154:415–23.
Tsoukas A, Ikonomidis I, Cokkinos P, et al. Significance of persistent left ventricular dysfunction during recovery after dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:621–6.
Soman P, Lahiri A, Senior R. Vasodilator stress induces infrequent wall thickening abnormalities compared to perfusion defects in mild to moderate coronary artery disease: implications for the choice of imaging modality with vasodilator stress. Echocardiography. 2004;21:307–12.
Fleischmann KE, Hunink MGM, Kuntz KM, et al. Exercise echocardiography or exercise SPECT imaging? JAMA. 1998;280:913–20.
Senior R, Becher H, Monaghan M, et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr. 2009;10(2):194–212.
Senior R, Khattar R, Lahiri A. Value of dobutamine stress echocardiography for the detection of multivessel coronary artery disease. Am J Cardiol. 1998;81:298–301.
Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography. A strategy for combination with the Duke treadmill score. Circulation. 2001;29:2566–71.
McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144–9.
Sicari R, Pasanisi E, Venneri L, et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol. 2003;41:589–95.
Poldermans D, Fioretti PM, Boersma E, et al. Dobutamine–atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med. 1994;97:119–25.
Severi S, Picano E, Michelassi C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation. 1994;89:1160–73.
Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007;49:227–37.
Chelliah R, Anantharam B, Burden L, et al. Independent and incremental value of stress echocardiography over clinical and stress electrocardiographic parameters for the prediction of hard cardiac events in new-onset suspected angina with no history of coronary artery disease. Eur J Echocardiogr. 2010;11:875–82.
Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754–60.
Chaowalit N, Arruda AL, McCully RB, et al. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol. 2006;47:1029–36.
Yao SS, Qureshi E, Sherrid MV, et al. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol. 2003;42:1084–90.
Shaw LJ, Berman DS, Picard MH, et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging. 2014;7:593–604.
Elhendy A, Arruda AM, Mahoney DW, et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol. 2001;37:1551–7.
Cortigiani L, Borelli L, Raciti M, et al. Prediction of mortality by stress echocardiography in 2835 diabetic and 11 305 nondiabetic patients. Circ Cardiovasc Imaging. 2015;8
Cortigiani L, Sicari R, Bigi R, et al. Impact of gender on risk stratification by stress echocardiography. Am J Med. 2009;122:301–9.
Cortigiani L, Dodi C, Paolini EA, et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol. 1998;32:1975–81.
Consensus Statement AHA. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation. 2014;130:350–79.
Clinical trial : NCT02346565.
Williams MA, Fleg JL, Ades PA, et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2002;105:1735–43.
Gurunathan S, Ahmed A, Pabla J, et al. The clinical efficacy and long-term prognostic value of stress echocardiography in octogenarians. Heart. 2017;103:517–23.
Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation. 2005;112:1444–50.
Gaibazzi N, Reverberi C, Lorenzoni V, et al. Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography. Circulation. 2012;126:1217–24.
Dawson D, Kaul S, Peters D, et al. Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography. J Am Soc Echo. 2009;22:954–60.
Kaul S, Senior R, Dittrich H, et al. Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation. 1997;96:785–92.
Dijkmans RA, Senior R, Becher H, et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol. 2006;48:2168–77.
•• Senior R, Moreo A, Gaibazzi N, et al. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. J Am Coll Cardiol. 2013;62:1353–61. The first large multicentre study comparing myocardial contrast echocardiography to SPECT perfusion imaging with invasive angiography as the gold standard
Shah BN, Gonzalez-Gonzalez AM, Drakopoulou M, et al. The incremental prognostic value of the incorporation of myocardial perfusion assessment into clinical testing with stress echocardiography study. J Am Soc Echocardiogr. 2015;28:1358–65.
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2014 Sep 1;35(33):2260–1.
Ingul CB, Stoylen A, Slordahl SA, et al. Automated analysis of myocardial deformation at dobutamine stress echocardiography: an angiographic validation. J Am Coll Cardiol. 2007 Apr 17;49(15):1651–9.
Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr. 2011;12:167–205.
Lang RM, Badano LP, Tsang W, et al. American Society of Echocardiography; European Association of Echocardiography. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2012;13:1–46.
Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372:1291–300.
The SCOT-HEART Investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385:2383–91.
Marwick TH, Shaw L, Case C, et al. Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J. 2003;24:1153–63.
•• Zacharias K, Ahmed A, Shah BN et al. Relative clinical and economic impact of exercise echocardiography vs. exercise electrocardiography, as first line investigation in patients without known coronary artery disease and new stable angina: a randomized prospective study. Eur Heart J Cardiovasc Imaging. 2016;18(2):195–202. The first randomized study of SE and Ex-ECG demonstrating that in the short term, SE was the more cost-efficient strategy.
Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7:1025–38.
Ahmadvazir S, Zacharias K, Shah BN, et al. Role of simultaneous carotid ultrasound in patients undergoing stress echocardiography for assessment of chest pain with no previous history of coronary artery disease. Am Heart J. 2014;168:229–36.
•• Ahmadvazir S, Shah BN, Zacharias K, Senior R.Incremental prognostic value of stress echocardiography with carotid ultrasound for suspected CAD JACC Cardiovasc Imaging. 2017. The first study showing the adjunctive prognostic value of carotid ultrasonography in patients undergoing SE.
Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539–42.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Roxy Senior has received speaker fees from Bracco (Italy), Phillips (Netherlands) and Lantheus Medical Imaging.
Sothinathan Gurunathan has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Gurunathan, S., Senior, R. Stress Echocardiography in Stable Coronary Artery Disease. Curr Cardiol Rep 19, 121 (2017). https://doi.org/10.1007/s11886-017-0935-x
Published:
DOI: https://doi.org/10.1007/s11886-017-0935-x